Sugiura Hirotaka | The Division of Cardiology Niigata University Graduate School of Medical and Dental Sciences

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Comparison of Efficacy of Sotalol and Nifekalant for Ventricular Tachyarrhythmias(CLINICAL INVESTIGATION)
Nifekalant Hydrochloride Suppresses Severe Electrical Storm in Patients With Malignant Ventricular Tachyarrhythmias
Relationship Between Clinical Characteristics and Conduction Delay in the RVOT in Brugada Syndrome : Investigation of Signal-Averaged ECG in Precordial Leads(ECG/Body Surface Potential Mapping/Holter 2 (A), The 69th Annual Scientific Meeting of the Japane
Role of Combined Medication Therapy for ICD Patients : Prognosis and ICD Discharge(Sudden Cardiac Death (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
PE-109 The Results of Electrophysiological Study for Nifekalant can Predict the Efficacy of Chronic Sotalol Treatment in Patients with Ventricular Tachyarrhythmia.(Arrhythmia, Pharmacological Therapy 1 (A) : PE19)(Poster Session (English))
OJ-429 Antiarrhythmic effects of magnesium sulfate for ventricular tachyarrhythmia developed under the condition of QT interval prolongation(ECG/Body Surface Potential Mapping/Holter 6 (A) : OJ52)(Oral Presentation (Japanese))
OJ-234 Possibility and Problems to resume driving in patients with Implantable-Cardioverter Defibrillator (ICD) : Estimated risk of future ICD therapy(Arrhythmia, Diagnosis/Pathophysiology/EPS 9 (A) : OJ27)(Oral Presentation (Japanese))
OE-335 Sotalol Treatment is Useful and Safe in Patients with Ventricular Tachyarrhythmias and Left Ventricular Dysfunction(Arrhythmia, Pharmacological Therapy 4 (A): OE42)(Oral Presentation (English))
OE-334 Electrocardiographic Effects of Quinidine in Brugada Syndrome : Is It Beneficial or Not?(Arrhythmia, Pharmacological Therapy 4 (A): OE42)(Oral Presentation (English))
OE-329 Ventricular tachyarrhytmia developed during treatment with class III antiarrhythmic drugs : arrhythmogenesis of slow heart rate and sympathetic nerve activity(Arrhythmia, Pharmacological Therapy 4 (A): OE42)(Oral Presentation (English))
The Efficacy of DL-Sotalol in Reentrant Ventricular Tachycardia with Special Reference to the Width of the Zone of Entrainment
Difference in Ventricular Fibrillation interval between Structural Heart Disease and Brugada Syndrome : Role of Sotalol Treatmentand Defibrillation Threshold
Severe Electrical Storm in Patients with Implantable CardioverterDefibrillators (ICD) : Does It Predict Poor Prognosis?
Long-Term Outcomes of EP-Guided Sotalol Treatment for Sustained Ventricular Tachyarrhythmias
Clinical characteristics of patients with inappropriate implantable cardioverter defibrillator(ICD)therapies : indication for dual-chamber ICD for sinus tachycardia
Intramural Arrhythmogenesis of ECG Phenomenon of Prolonged QT Interval, Short-Long Cardiac Cycle and T Wave Alternans in Long QT Syndrome
Arrhythmogenesis of Sympathetic Activity Related Ventricular Tachyarrhythmias in Type 3 Long QT Syndrome (LQT3)
Ventricular Tachyarrhythmias in a Canine Model of LQT3 Arrhythmogenic Effects of Sympathetic Activity

もっと見る

スポンサーリンク